Skip to main content

Table 7 Selected cardiovascular adverse events during drug administration

From: Comparative effects of recombinant human brain natriuretic peptide and dobutamine on acute decompensated heart failure patients with differsent blood BNP levels

Adverse events High BNP group Extra-high BNP group
  Dobutamine (n = 30) rhBNP (n = 28) P value Dobutamine (n = 23) rhBNP (n = 24) P value
Symptomatic hypotension 0 0 1.000 0 1 1.000
Asymptomatic hypotension 0 2 0.229 0 3 0.234
Sustained VT 0 0 1.000 0 0 1.000
Nonsustained VT 2 0 0.492 2 1 0.609
VF 0 0 1.000 0 0 1.000
Sudden death 0 0 1.000 0 0 1.000
Cardiac arrest 0 0 1.000 0 0 1.000
  1. Abbrevations: VF ventricular fibrillation, VT ventricular tachycardia, Other abbreviations are same as in Table 2. Fisher exact text was used.